Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word

Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.

Ladich believes that “we need to take a step back” and evaluate the data because “the truth takes time”.

Meanwhile, Greenhalgh, emphasises the trade-off in terms of risk and benefit that clinicians have to consider when using these devices in appropriately consented patients.

Ladich, Elena and Greenhalgh, Roger

Add comment

Editor’s Peripheral Pick

    Subscribe to receive the very best in medical videos

    /* ]]> */